Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation for Individualized Noninvasive Neuromodulation in Neurorehabilitation of Brain Disease: Longitudinal Study

NCT03390192 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03390192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03390192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation for Individualized Noninvasive Neuromodulation in Neurorehabilitation of Brain Disease: Longitudinal Study
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 13, 2015
Completion date
March 13, 2018
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke